Peter Mueller, EVP, Global R&D, CSO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 7,500 shares at $82.55 ($619K) on 2014-02-18, disclosed to the SEC on 2014-02-20.
Scheduled sale ($619k) by EVP, Global R&D, CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.55 | 6,867 | $567K | 91.5% |
| 2 | $83.05 | 633 | $53K | 8.5% |
| Total | $82.59 avg | 7,500 | $619K | 100% |
| Filing → |
| BTAI | BUY | 2018-12-07 | $44K | — | Filing → |
| BTAI | BUY | 2018-12-06 | $21K | — | Filing → |
| VRTX | SELL | 2014-06-18 | $512K | — | Filing → |